Westeel V, Barlesi F, Foucher P, et al. Results of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC). ESMO 2017 Congress; abstract 1273O (updated results in ESMO Press Release, 31 August 2017).
Alectinib versus crizotinib bij ALK-positief NSCLC
jun 2017 | Longoncologie